ohdsi-questions
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision | Next revision Both sides next revision | ||
|
ohdsi-questions [2018/04/13 23:45] rohit |
ohdsi-questions [2018/04/13 23:48] rohit |
||
|---|---|---|---|
| Line 63: | Line 63: | ||
| -Outcome - Osteoporosis or Fracture. | -Outcome - Osteoporosis or Fracture. | ||
| -Risk Window: From the first day of treatment with high or low strength levothyroxine until the end of cohort study, end of follow-up or death. | -Risk Window: From the first day of treatment with high or low strength levothyroxine until the end of cohort study, end of follow-up or death. | ||
| + | |||
| + | ===Question - 10=== | ||
| + | To compare the risk of chronic kidney disease (CKD) among patients exposed to proton pump inhibitors versus patients not exposed to proton pump inhibitors. | ||
| + | -Treatment Cohort - Patients with chronic exposure to proton pump inhibitors, age >= 18 years heaving no evidence of chronic kidney disease (eGFR < 60ml/min). | ||
| + | -Comparator Cohort - Patients of age >= 18 with no exposure to proton pump inhibitors. | ||
| + | -Outcome - Incidence of chronic kidney disease. | ||
| + | |||
| + | ===Question - 11=== | ||
| + | To compare the risk of Atherosclerotic Cardiovascular Disease (ACD) between patients with a diagnosis of hyperlipidemia (HLD) on statins and elevated triglycerides treated with fibrates versus patients with a diagnosis of HLD on statins and elevated triglycerides not treated with fibrates. | ||
| + | -Treatment Cohort - Patients with a diagnosis of HLD on statins and elevated triglycerides treated with fibrates. | ||
| + | -Comparator cohort - Patients with a diagnosis of HLD on statins and elevated triglycerides not treated with fibrates. | ||
| + | -Outcome - Occurrence of Atherosclerotic Cardiovascular disease after treatment. | ||
| + | -Risk Window - 1 day after exposure start to 0 days after exposure ends. | ||
| + | |||
| + | ===Question - 12=== | ||
| + | To compare the risk of Atherosclerotic Cardiovascular Disease (ACD) between patients with a diagnosis of hyperlipidemia (HLD) on statins with ideal cholesterol versus patients with a diagnosis of HLD on statins with elevated cholesterol. | ||
| + | -Treatment Cohort - Patients with the diagnosis of HLD treated with statins and have ideal cholesterol level. | ||
| + | -Comparator Cohort - Patients with the diagnosis of HLD treated with statins and have elevated cholesterol level. | ||
| + | -Outcome - Risk of ACD. | ||
| + | -Risk Window - 30 days after exposure to statins to 0 days after exposure. | ||
| + | |||
| More discussion on these question can be seen here at [[http:// | More discussion on these question can be seen here at [[http:// | ||
ohdsi-questions.txt · Last modified: 2018/06/04 20:14 by nigam
Page Tools
